You're using an outdated browser. This website will not display correctly and some features will not work.
Learn more about the browsers we support for a faster and safer online experience.

Important: This version of the e-Laws website will be upgraded to a new version in the coming weeks.
You can try the beta version of the new e-Laws at ontario.ca/laws-beta.

 

ontario regulation 285/15

made under the

Drug Interchangeability and Dispensing Fee Act

Made: September 16, 2015
Filed: September 18, 2015
Published on e-Laws: September 18, 2015
Printed in The Ontario Gazette: October 3, 2015

Amending Reg. 935 of R.R.O. 1990

(GENERAL)

1. (1) Subsection 6 (5) of Regulation 935 of the Revised Regulations of Ontario, 1990 is amended by striking out “volume” in the portion before paragraph 1 and substituting “strength”.

(2) Section 6 of the Regulation is amended by adding the following subsections:

(7.1) Clause (1) (h) does not apply to a dermatological product that contains one or more glucocorticoids as the only active ingredient or ingredients and that has been designated by Health Canada as equivalent to the original product or to another listed interchangeable product with which it would be designated as interchangeable.

(7.2) Clause (1) (h) does not apply to a product with a transdermal route of administration for systemic effect that has been designated by Health Canada as equivalent to the original product or to another listed interchangeable product with which it would be designated as interchangeable.

Commencement

2. This Regulation comes into force on October 1, 2015.